Company intelligence / Profile preview

DioTree

Anyang-si, Gyeonggi-do, South Koreadiotree.com ↗

Ownership: Private
Development stage: Other

Overview

DioTree is a South Korean biotechnology company specializing in the development of advanced molecular diagnostic systems and precision medicine solutions. The company focuses on high-sensitivity detection technologies, including digital PCR (dPCR) and isothermal amplification platforms, to provide accurate diagnostic tools for infectious diseases, oncology, and genetic testing. DioTree's product portfolio includes automated nucleic acid extraction systems and specialized diagnostic kits designed for point-of-care and laboratory settings. By integrating microfluidics and digital signal processing, the company aims to improve the speed and reliability of molecular testing in clinical environments.

Therapeutic areas: Infectious DiseasesRare DiseasesOncology
Modalities: DiagnosticMedical DeviceSoftware as a Medical Device
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on DioTree.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DioTree.